Speakers

2025 Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 8th TPD & Induced Proximity Summit.

Trailblazing Academic Leaders

Founders & C-Level Leaders

Biopharma Industry Leaders

Trailblazing Academic Leaders

Craig Crews

John C. Malone Professor of Molecular, Cellular, & Developmental Biology
Yale University

Victor Guallar

Chief Scientific Officer
Barcelona Supercomputing Center

Katherine Donovan

scientist
Dana-Farber Cancer Institute

Christina Woo

Professor of Chemistry and Chemicall Biology
Harvard University

Zoran Rankovic

Professor ,Director - Centre for Protein Degradation & Chemical Biology
Institute of Cancer Research

Founders & C-Level Leaders

Raymond Deshaies

Former Distinguished Fellow
Amgen Inc.

Angela Cacace

CSO
Arvinas, Inc.

Arthur Sands

Chief Executive Officer
Nurix Therapeutics, Inc.

Antony Mattessich

Chief Executive Officer
Amphista Therapeutics

Louise Modis

Chief Scientific Officer
Amphista Therapeutics

Neil Torbett

Chief Executive Officer
PhoreMost

Benedict Cross

Chief Technology Officer & Head of Platform
PhoreMost

Steven Bellon

Chief Scientific Officer
Foghorn Therapeutics

David Millan

David Millan

Chief Scientific Officer
Auron Therapeutics

Randolph Lopez

CTO
A-Alpha Bio Inc.

Zachary Rosenthal

CEO, Founder
Birdwood Therapeutics

Yong Cang

Chief Scientific Officer & Co-founder
Degron Therapeutics

Simon Glerup

CSO
Draupnir Bio Aps

Shyra Gardai

Chief Scientific Officer
EpiBiologics

Anna Rivkin

CBO
Foghorn Therapeutics

Anita Bellail

CEO
HB Therapeutics, Inc.

Lawrence Hamann

Co-founder, President and CEO
Interdict Bio

Krista Goodman

Chief Scientific Officer
Larkspur Biosciences

Nan Ji

CEO
PAQ Therapeutics

Hyunsun Jo

Founder & Chief Executive Officer
Pin Therapeutics

Dominic Reynolds

Chief Scientific Officer
Remix Therapeutics

Chris Tame

Founder & Chief Executive Officer
Ternary Therapeutics

Nicki Thompson

Chief Executive Officer
Trimtech Therapeutics

Henrik Daub

Chief Scientific Officer
NEOsphere Biotechnologies GmbH

Daohong Zhou

Professor
The University of Texas Health Science Center at Houston (UTHealth Houston)

Gwenn M. Hansen

Chief Scientific Officer
Nurix Therapeutics, Inc.

Michael Dabrowski

CEO
Pelago Bioscience

Joey Azofeifa

Chief Executive Officer & Co-Founder
Arpeggio Bio

Jason Xiang

Chief Executive Officer & Founder
Polymed Biopharmaceuticals

Maria Soloveychik

CEO
SyntheX

Bradley brasher

CSO
Trilogie Bioscience

Eyal Attar

Chief Medical Officer
Halda Therapeutics, LLC

Matthias Brand

Chief Technology Officer & Co-founder
Proxygen GmbH

Zhiyong Wang

Founder & Chief Scientific Officer
Venquis Therapeutics

Biopharma Industry Leaders

Juliet Williams

Head Of Research
Kymera Therapeutics

Mathew Sowa

Vice President of Lead Discovery
C4 Therapeutics

David Barrett

Head Of Engineered Small Molecules & Oncolgy Research
Astellas Pharma

Aly Jackson

Business Development Project Leader, Pharma Partnering
Genentech

Ian Churcher

CEO & Founder
Janus Drug Discovery Consulting Ltd

Qi Wan

Principal Scientist
Abbvie

Rene Lemieux

Senior Vice President ,Head of Drug Discovery Sciences
Avilar Therapeutics

Esther Lee

Associate Director of Medicinal Chemistry
AstraZeneca

Maureen Galmes-Spit

Vice President - Research
Laigo Bio

Minoru Tanaka

Director
Mitsubishi Tanabe Pharma

Lingling Shen

Associate Director - Chemoinformatics & Discovery AI
Novartis AG

Markus Haeberlein

Executive Vice President - Discovery Science
Parabilis Medicines

Takeru Furuya

Principal
Perceptive Advisors LLC

Feng Wang

Head of Protein Homeostasis Group & Associate Fellow - Research
Pfizer

Prakash Palde

Director - Biophysics, High Throughput Screening & Oncology
Pfizer

Koichi Ito

Senior Director - Biology
Prelude Therapeutics

Jack Carter

Director
Prelude Therapeutics

Derek Taylor

Head of Structural Biology (Rappta Therapeutics); Professor (Case Western Reserve University)
Rappta Therapeutics

Sanjiv Shah

Executive Director, Discovery Science
Revolution Medicines

Nicholas Endres

Principal Scientist
Genentech

Xiaoqi Liu

Senior Director, Head of Business Development & Strategic Finance
Degron Therapeutics

Kristin Riching

R&D Group Leader
Promega Corporation

Michael Drummond

Principal Scientist
Chemical Computing Group

Greg Parker

Senior Director - Biology
Plexium Inc.

Chris Nasveschuk

Senior Vice-President of Chemical Sciences
C4 Therapeutics Inc

Dana Klug

Research Investigator
Arvinas, Inc.

James Gregory

Associate Director
Arvinas, Inc.

Amine Sadok

Director - Induced Proximity Platform
Amgen Inc.

Christopher Phelps

Senior Vice President & Head of Early Drug Discovery
Nurix Therapeutics

Mark Noviski

Associate Director, Cell Biology & Project Lead
Nurix Therapeutics, Inc.

Changhoon Ji

Executive Director
AUTOTAC Bio

Jing liu

SVP
Cullgen Inc.

Kazuteru Aoki

Vice President, Biology
FIMECS

Wu Du

Senior Vice President - Medicinal Chemistry
Hinova Pharmaceuticals

Morgan Oshea

Director
Larkspur Biosciences

Kevin Freeman-Cook

SVP chemistry
Plexium Inc.

Muhammad Shahzad Ali

Assistant Director
LifeSensors Inc

Jan Schnatwinkel

Senior Application Scientist
NanoTemper Technologies

Bret Williams

SVP, Research
Magnet Biomedicine

Catherine Henry

Nikhil Jain

Associate Director of Discovery, Strategy & Business Development
SAI Life Sciences Ltd

Hongbo zhang

Flavio Lima Bianchi

Research Analyst
Beacon

Moses Moustakim

Principal Scientist
Photys Therapeutics

Hunter Goble

Chief Executive Officer
Transcera Inc.

Eddine Saiah

Chief Scientific Officer
Stablix

Join Biopharma Experts

Explore the 2025 Agenda

Hear the latest industry breakthroughs and gain exclusive insights on the TPD innovations during our packed agenda, interactive roundtables, and new CCOs & VC panel discussions.

View Presentations & Speakers

Partner With Us

Partner With Us

Position yourself alongside as the leading solution provider to ensure your brand is at the heart of TPD biopharma deals.

Explore Sponsorship Options

Explore the Agenda

Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.